Author:
Pan Jing-hua,Zhou Hong,Cooper Laura,Huang Jin-lian,Zhu Sheng-bin,Zhao Xiao-xu,Ding Hui,Pan Yun-long,Rong Lijun
Funder
National Natural Science Foundation of China
Subject
Immunology,Immunology and Allergy
Reference43 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J Clin.,2017
2. Immunotherapy in gastrointestinal cancers;Procaccio;J Gastrointest Oncol.,2017
3. Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology;Barbee;Ann Pharmacother.,2015
4. Pembrolizumab for the treatment of non–small-cell lung cancer;Garon;N Engl J Med.,2015
5. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer;Chung;J Clin Oncol.,2010
Cited by
260 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献